Revance Therapeutics Inc. buy Maxi_Scalibusa
Start price
17.02.19
/
50%
€15.82
Target price
03.04.19
€27.06
Performance (%)
-14.60%
End price
03.04.19
€13.51
Summary
This prediction ended on 03.04.19 with a price of €13.51. The prediction for Revance Therapeutics Inc. disappointed with a performance of -14.60%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0,85 % | 1,37 % | 2,61 % | 52,29 % |
| iShares Nasdaq 100 | -0,99 % | -3,84 % | 25,55 % | 78,88 % |
| iShares Nikkei 225® | -1,78 % | -8,53 % | 42,81 % | 65,51 % |
| iShares S&P 500 | 0,06 % | 0,61 % | 21,57 % | 63,55 % |
Comments by Maxi_Scalibusa for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Revance Therapeutics
(Stop Loss Kurs erreicht)


